Alembic Pharmaceuticals Ltd.

BSE: 533573 | NSE: APLLTD |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE901L01018 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Alembic Pharma Alembic Pharmaceuticals Ltd. | BSE 800.70 -12.75 (-1.57%) | NSE 799.95 -14.80 (-1.82%) | Trade | Add

BSE Live

Jan 09, 16:01

800.70 -12.75 (-1.57%)

Volume

AVERAGE VOLUME

5-Day

5,204

10-Day

4,156

30-Day

3,698

4,152

Prev. Close

813.45
Open Price

808.30

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)

NSE Live

Jan 09, 15:59

799.95 -14.80 (-1.82%)

Volume

AVERAGE VOLUME

5-Day

79,823

10-Day

53,037

30-Day

54,050

89,204

Prev. Close

814.75
Open Price

815.80

Bid Price (Qty.)
799.95 (1)
Offer Price (Qty.)
0.00 (0)

Financials

Print/Copy to Excel : Go

Balance Sheet of Alembic Pharmaceuticals (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	39.31	39.31	39.31	39.31	39.31
Total Share Capital	39.31	39.31	39.31	39.31	39.31
Reserves and Surplus	5,155.43	4,869.60	4,374.98	5,251.03	5,214.93
Total Reserves and Surplus	5,155.43	4,869.60	4,374.98	5,251.03	5,214.93
Total Shareholders Funds	5,194.74	4,908.91	4,414.29	5,290.34	5,254.24
NON-CURRENT LIABILITIES
Long Term Borrowings	0.00	0.00	0.00	0.00	199.89
Deferred Tax Liabilities [Net]	0.00	0.00	0.00	46.40	46.12
Other Long Term Liabilities	37.62	52.91	58.63	62.03	67.73
Long Term Provisions	124.31	109.51	106.20	95.82	84.73
Total Non-Current Liabilities	161.93	162.42	164.83	204.25	398.47
CURRENT LIABILITIES
Short Term Borrowings	1,142.22	420.04	635.07	629.99	0.02
Trade Payables	724.57	619.96	595.86	570.21	516.94
Other Current Liabilities	247.54	222.33	250.41	315.61	554.91
Short Term Provisions	85.27	64.88	69.96	63.64	51.60
Total Current Liabilities	2,199.60	1,327.21	1,551.30	1,579.45	1,123.47
Total Capital And Liabilities	7,556.27	6,398.54	6,130.42	7,074.04	6,776.18
ASSETS
NON-CURRENT ASSETS
Tangible Assets	2,513.47	2,535.66	2,377.45	1,714.72	1,452.83
Intangible Assets	0.00	0.00	0.00	56.38	0.00
Capital Work-In-Progress	837.23	524.36	601.28	2,205.79	1,927.63
Other Assets	0.00	0.00	0.00	0.00	8.35
Fixed Assets	3,350.70	3,060.02	2,978.73	4,075.33	3,388.81
Non-Current Investments	259.56	226.68	229.27	219.36	978.25
Deferred Tax Assets [Net]	77.42	78.83	78.16	0.00	0.00
Long Term Loans And Advances	71.24	11.16	10.29	0.00	0.00
Other Non-Current Assets	31.15	33.30	53.75	34.89	35.17
Total Non-Current Assets	3,790.07	3,409.99	3,350.20	4,329.58	4,402.23
CURRENT ASSETS
Current Investments	0.00	0.00	0.00	0.00	186.97
Inventories	1,976.34	1,353.07	1,275.13	1,396.83	1,316.78
Trade Receivables	1,480.67	1,340.12	1,201.20	988.33	407.90
Cash And Cash Equivalents	20.85	26.49	28.46	21.90	61.22
Short Term Loans And Advances	12.88	0.00	0.00	0.00	0.00
OtherCurrentAssets	275.46	268.87	275.43	337.40	401.08
Total Current Assets	3,766.20	2,988.55	2,780.22	2,744.46	2,373.95
Total Assets	7,556.27	6,398.54	6,130.42	7,074.04	6,776.18
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	240.49	193.55	326.18	228.15	327.06
CIF VALUE OF IMPORTS
Raw Materials	0.00	0.00	0.00	0.00	0.00
Stores, Spares And Loose Tools	0.00	0.00	0.00	0.00	0.00
Trade/Other Goods	0.00	0.00	0.00	0.00	0.00
Capital Goods	0.00	0.00	0.00	0.00	0.00
EXPENDITURE IN FOREIGN EXCHANGE
Expenditure In Foreign Currency	1,229.26	804.89	684.56	672.76	684.49
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS
Dividend Remittance In Foreign Currency	--	--	--	--	--
EARNINGS IN FOREIGN EXCHANGE
FOB Value Of Goods	--	--	--	--	--
Other Earnings	3,412.99	3,182.64	2,621.00	2,325.09	3,602.01
BONUS DETAILS
Bonus Equity Share Capital	--	--	--	--	--
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	--	--	--	--	--
Non-Current Investments Unquoted Book Value	259.56	226.68	229.27	219.36	978.25
CURRENT INVESTMENTS
Current Investments Quoted Market Value	--	--	--	--	--
Current Investments Unquoted Book Value	--	--	--	--	--